blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1406857

EP1406857 - SUBSTITUTED 1-ARYL-BUT-3-ENYLAMINE AND 1-ARYL-BUT-2-ENYLAMINE COMPOUNDS [Right-click to bookmark this link]
Former [2004/16]SUBSTITUTED 1-ARYL-BUT-3-ENYLAMINE AND 1-ARY-BUT-2-ENYLAMINE COMPOUNDS
[2006/52]
StatusNo opposition filed within time limit
Status updated on  28.12.2007
Database last updated on 03.10.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR
published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Grünenthal GmbH
Zieglerstrasse 6
52078 Aachen / DE
[2004/16]
Inventor(s)01 / SUNDERMANN, Bernd
Oppenhofallee 83-85
52066 Aachen / DE
02 / MAUL, Corinna
Oppenhoffallee 83-85
52066 Aachen / DE
03 / BUSCHMANN, Helmut
Carrer Est, 24
E-08950 Esplugues de Llobregat / ES
04 / KÖGEL, Babette-Yvonne
Am Deans 28
52379 Langerwehe-Hamaich / DE
 [2004/16]
Application number, filing date02754818.903.07.2002
[2004/16]
WO2002EP07381
Priority number, dateDE200113274705.07.2001         Original published format: DE 10132747
[2004/16]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03004452
Date:16.01.2003
Language:DE
[2003/03]
Type: A1 Application with search report 
No.:EP1406857
Date:14.04.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 16.01.2003 takes the place of the publication of the European patent application.
[2004/16]
Type: B1 Patent specification 
No.:EP1406857
Date:21.02.2007
Language:DE
[2007/08]
Search report(s)International search report - published on:EP16.01.2003
ClassificationIPC:C07C211/28, A61P25/04, A61P25/24, A61P25/28, A61P27/00, A61K31/137
[2004/16]
CPC:
C07C211/28 (EP,US); A61P25/00 (EP); A61P25/04 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P27/00 (EP);
C07C211/26 (EP,US); C07C211/29 (EP,US); C07C2601/16 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/16]
Extension statesALNot yet paid
LT05.02.2004
LV05.02.2004
MKNot yet paid
RO05.02.2004
SI05.02.2004
TitleGerman:SUBSTITUIERTE 1-ARYL-BUT-3-ENYLAMIN- UND 1-ARYL-BUT-2-ENYLAMINVERBINDUNGEN[2006/52]
English:SUBSTITUTED 1-ARYL-BUT-3-ENYLAMINE AND 1-ARYL-BUT-2-ENYLAMINE COMPOUNDS[2006/52]
French:COMPOSES DE 1-ARYL-BUT-3-ENYLAMINES ET 1-ARYL-BUT-2-ENYLAMINES SUBSTITUES[2006/52]
Former [2004/16]SUBSTITUIERTE 1-ARYL-BUT-3-ENYLAMIN- UND 1-ARY-BUT-2-ENYLAMINVERBINDUNGEN
Former [2004/16]SUBSTITUTED 1-ARYL-BUT-3-ENYLAMINE AND 1-ARY-BUT-2-ENYLAMINE COMPOUNDS
Former [2004/16]COMPOSES DE 1-ARYL-BUT-3-ENYLAMINES ET 1-ARY-BUT-2-ENYLAMINES SUBSTITUES
Entry into regional phase05.02.2004National basic fee paid 
05.02.2004Designation fee(s) paid 
05.02.2004Examination fee paid 
Examination procedure14.09.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
05.02.2004Examination requested  [2004/16]
10.07.2006Communication of intention to grant the patent
20.10.2006Fee for grant paid
20.10.2006Fee for publishing/printing paid
Opposition(s)22.11.2007No opposition filed within time limit [2008/05]
Fees paidRenewal fee
14.07.2004Renewal fee patent year 03
13.07.2005Renewal fee patent year 04
12.07.2006Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY21.02.2007
CZ21.02.2007
DK21.02.2007
EE21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
TR21.02.2007
BG15.05.2007
SE21.05.2007
GR22.05.2007
LU03.07.2007
PT23.07.2007
MC31.07.2007
[2009/42]
Former [2009/38]CY21.02.2007
CZ21.02.2007
DK21.02.2007
EE21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
GR22.05.2007
LU03.07.2007
PT23.07.2007
MC31.07.2007
Former [2009/34]CY21.02.2007
CZ21.02.2007
DK21.02.2007
EE21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
GR22.05.2007
PT23.07.2007
MC31.07.2007
Former [2009/10]CZ21.02.2007
DK21.02.2007
EE21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
GR22.05.2007
PT23.07.2007
MC31.07.2007
Former [2008/22]CZ21.02.2007
DK21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
GR22.05.2007
PT23.07.2007
MC31.07.2007
Former [2008/02]CZ21.02.2007
DK21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
PT23.07.2007
Former [2007/51]DK21.02.2007
FI21.02.2007
IE21.02.2007
SK21.02.2007
BG15.05.2007
SE21.05.2007
PT23.07.2007
Former [2007/48]DK21.02.2007
FI21.02.2007
IE21.02.2007
BG15.05.2007
SE21.05.2007
PT23.07.2007
Former [2007/46]DK21.02.2007
FI21.02.2007
BG15.05.2007
SE21.05.2007
Former [2007/38]FI21.02.2007
BG15.05.2007
SE21.05.2007
Cited inInternational search[A]DE963424  (THOMAE GMBH DR K) [A] 1-30 * page 2, line 56 - line 68 * * page 3, line 24 - line 25 * * page 3, line 58 - line 104 * * example 14 * * Eintragungen 3-4 auf Seite 13 und 5-6 auf Seite 18;; claim 1 *;
 [A]US3564100  (FRANKUS ERNST, et al) [A] 1-30 * Formel I und IV; column 2, line 11 - line 13; claim 1 *;
 [A]US5811582  (BUSCHMANN HELMUT HEINRICH [DE], et al) [A] 1-30 * Beispiele insbesondere Beispiel 26; column 1, line 5 - column 5, line 11; claims 1-6 *;
 [A]  - LEDNICER D ET AL, "PARTLY REDUCED BIPHENYLS AS CENTRAL NERVOUS SYSTEM AGENTS 1. 4-ARYLCYCLOHEX-3-ENYLAMINES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1972), vol. 15, no. 12, ISSN 0022-2623, pages 1235 - 1238, XP000990795 [A] 1-30 * Schema II, Komponente 9, 10, 13, 14;; tables I,VI *

DOI:   http://dx.doi.org/10.1021/jm00282a008
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.